Journal article
Variation in mantle technique: implications for establishing priorities for quality assurance in clinical trials
Abstract
74 European and American radiotherapists responded to a questionnaire investigating the treatment of a patient with stage IIA non-bulky Hodgkin's disease by mantle irradiation. A consensus was present for the dose aims to involved and uninvolved lymph nodes and the acceptable incidence of late normal tissue effects. There was less agreement as to the total dose and dose per fraction required to maintain normal tissue toxicity within the agreed …
Authors
Sebag-Montefiore DJ; Maher EJ; Young J; Hudson GV; Hanks G
Journal
Radiotherapy and Oncology, Vol. 23, No. 3, pp. 144–149
Publisher
Elsevier
Publication Date
March 1992
DOI
10.1016/0167-8140(92)90324-n
ISSN
0167-8140